May 17, 2022 12:55 PM EDTUpdated 01:08 PM
Pharma
Marketing

MRx roundup: Ho­log­ic en­lists Sh­eryl Crow for screen­ings; J&J Quick­Fire teams with feds for pub­lic health

Beth Snyder Bulik

Senior Editor

Ho­log­ic is adding an­oth­er ef­fort from Gram­my-win­ning mu­si­cian Sh­eryl Crow, who’s al­so a breast can­cer sur­vivor, to its most re­cent mar­ket­ing ef­forts. Crow, a long …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times